FIELD: medicinal industry. SUBSTANCE: method involves successive performing of the following procedures: preparing solution 1 - 4.1-5.1 mg insulin is dissolved in 1 ml 0.05N acetic acid aqueous solution; preparing solution 2 - nipagin is dissolved in 0.1N sodium hydroxide solution (4.6-6.8 mg in solution). Then both solutions are mixed, glycerol and water are added up to required volume. Preparation is sterilized by filtration, kept at temperature 1-5 C for 14-30 days, and after repeated sterilizing filtration is poured into small bottles. EFFECT: increased stability of insulin aqueous solution to low temperature. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING PHARMACEUTICAL COMPOSITION SOLUTION BASED ON SUBSTANCE OF GENE ENGINEERING (RECOMBINANT) HUMAN INSULIN | 2001 |
|
RU2184533C1 |
MEDICINAL PREPARATION FOR INJECTIONS | 1992 |
|
RU2093144C1 |
METHOD OF HEPARIN PREPARING | 1992 |
|
RU2042356C1 |
PREPARATION FOR TREATMENT OF BURN DISEASE OF EYE OF I-IV DEGREE | 1992 |
|
RU2073523C1 |
METHOD OF PREPARING PHARMACEUTICAL COMPOSITION SUSPENSION BASED ON SUBSTANCE OF GENETIC ENGINEERING (RECOMBINANT) HUMAN INSULIN | 2001 |
|
RU2185152C1 |
METHOD OF PREPARING PREPARATION "PENSULIN CC" OF INSULIN SUSPENSION FOR CARTRIDGE | 1999 |
|
RU2157698C1 |
METHOD OF PREPARING "PENSULIN CP" PREPARATION OF INSULIN SOLUTION FOR CARTRIDGE | 1999 |
|
RU2157238C1 |
METHOD FOR PREPARING QUICK ACTION INSULIN SOLUTION FOR MAKING INJECTIONS | 2001 |
|
RU2202365C2 |
METHOD OF DEXTRAN CLINICAL FRACTIONS PURIFICATION | 1991 |
|
RU2021284C1 |
AGENT FOR ARTHROLOGICAL DISEASES TREATMENT | 1992 |
|
RU2021812C1 |
Authors
Dates
1994-10-15—Published
1992-02-24—Filed